Introduction

Diabetes mellitus is an important global health issue as the number of people with diabetes are rising every year, particularly of type 2 diabetes [1]. Pakistan had an estimated population of 7.5 million diabetics as of 2017, and this population is predicted to near 16.1 million in 2045 [2]. The recent National diabetes survey of Pakistan is just completed and reports are sent for publication. People with type 2 diabetes mellitus have a considerably higher risk of both macrovascular complications (peripheral vascular disease, coronary artery disease, and cerebrovascular disease) and microvascular complications (nephropathy, neuropathy, and retinopathy) [3]. These complications result in significantly high morbidity and mortality. People with long duration of diabetes or uncontrolled disease are usually affected by microvascular complications. However, the complications can already be present at the time of diagnosis [4].

The increasing trend in the prevalence of microvascular complications of type 2 diabetes has been observed in various epidemiological studies [5,6,7,8]. Joint Asia Diabetes Evaluation (JADE) reported that in seven countries of Asia, retinopathy, neuropathy, and nephropathy affected 20.4, 15.0, and 7.5% of diabetic subjects, respectively [9]. Previous studies identified that the prevalence of microvascular complications was more common in Asians as compared to Europeans [10, 11] and Caucasians [8]. Data on prevalence rate of microvascular complications in Pakistan is scarce. However, a few small hospital-based studies highlighted high prevalence of microvascular complications ranged from 12 to 31% for retinopathy, 28 to 56% for nephropathy, and 36 to 68% for neuropathy [12,13,14,15,16,17]. The issue of rising type 2 diabetes in young individuals makes it significantly more important to identify and treat the disease earlier as the long-term microvascular complications are related with hyperglycemia and duration of the disease. Thus, the present study aims to assess the prevalence of microvascular complications and associated risk factors among subjects with type 2 diabetes reported at a tertiary care unit of Karachi, Pakistan.

Methodology

This retrospective study was conducted at Baqai Institute of Diabetology and Endocrinology (BIDE). Ethical approval for the study was obtained from the institutional review board (IRB) of BIDE. For this study, data records of the first visit of type 2 diabetic subjects (the time when the patient first consulted our institute for management) who attended outpatient department (OPD) of the institute from January 2005 to April 2016 were analyzed without any breach of confidentiality. Subjects of type 1 diabetes and gestational diabetes were not included in the study. Data obtained from computerized hospital management system (HMS) included risk factors of diabetes along with its microvascular complications. For screening of diabetic retinopathy, fundus was examined using Vista 20 direct ophthalmoscope by a diabetologist. The retinopathy was classified as normal background (presence of microdots and hard exudates), pre-proliferative and proliferative (presence of soft exudates and new vessels), or maculopathy [12, 13]. It also included subjects who had prior laser photocoagulation for diabetic retinopathy. Peripheral neuropathy was defined as absent touch or vibratory sensations of the feet. Touch sensation was assessed by 10 g monofilament and vibration sensation by 128 Hz tuning fork [12, 13]. Nephropathy was classified as protein > 1 plus on dipstick (Combur 10, Rouche Diagnostics) with no other abnormal findings on urinary examination [12, 13]. In case of urine dipstick negative, microalbuminuria was done by quantitative analysis. A result of more than 30 mg on at least two consecutive occasions is considered as positive for nephropathy [13].

Biochemical parameters were measured by standard laboratory test methods. A triglyceride > 150 mg/dl was considered to be hypertriglyceridemia. LDL cholesterol concentration was stated to be abnormal if it was > 100 mg/dl. Low HDL was considered at < 40 mg/dl for male and < 50 mg/dl for female. Hypercholesterolemia was defined as cholesterol over 160 mg/dl [18, 19].

HbA1c value of ≤ 7% and > 7% were taken as good and poor control. Body mass index (BMI) was calculated by the standard formula and obesity was taken as BMI > 25 kg/m2 [12, 13].

Statistical analysis

Descriptive analysis included the estimation of mean values and standard deviations for continuous variables. Prevalence or frequencies were expressed in terms of percentage. The Student’s t-test (for continuous variables) and chi-square test (for categorical variables) were employed to compare differences among the subgroups of the population. Association between microvascular complications and risk factors were examined using logistic regression. Variables significant at p value ≤ 0.25 in an initial univariate regression analysis were entered in a multiple regression model. Backward stepwise regression analysis was undertaken for model building. Odd ratios and 95% confidence interval were generated as a measure of association. The level of significance was set at p value < 0.05. All descriptive and comparative analyses were conducted in SPSS version 20.

Results

A total of 28,601 type 2 diabetic subjects were included in the study. Among them, 56.9% subjects had at least one microvascular complication. Subjects with microvascular complications were older than subjects without microvascular complication (54.4 ± 11.1 vs 50.1 ± 11.1 years) with longer duration of diabetes (9.8 ± 7.7 vs 6.0 ± 6.0 years) and increased BMI (28.3 ± 5.2 vs 27.8 ± 5.6 kg/m2). Significant differences were found between the groups in biochemical parameters except for triglycerides (Table 1).

Table 1 Association between variables (demographics, anthropometrics, biochemical, and clinical parameters) and diabetic complication

Figure 1 showed prevalence of various microvascular complications. Among the studied subjects, 15.8% had retinopathy, 31% had nephropathy, and 48.7% had neuropathy. High prevalence of all three microvascular complications was seen in subjects of older age and subjects who had poor glycemic control and longer duration of diabetes (Table 2).

Fig. 1
figure 1

Prevalence of microvascular complications at baseline

Table 2 Prevalence of microvascular complications according to different subgroups

Table 3 shows the results of univariate regression analysis demonstrating relationship between microvascular complications and their risk factors. Significant differences were observed between all the risk factors and microvascular complications except retinopathy which was not significantly associated with components of dyslipidemia.

Table 3 Univariate regression models

Potential risk factors which were significantly associated in univariate analysis were considered for inclusion in a multivariate logistic regression analysis. In multivariate analysis, the risk factors for having at least one microvascular complication were found to be male gender, age ≥ 40 years, duration of diabetes > 10 years, obesity, hypertension, HbA1c > 7%, and low high-density lipoprotein.

Nephropathy was found to be significantly associated with male gender, duration of diabetes > 10 years, hypertension, hbA1c > 7%, hypercholesterolemia, and low high-density lipoprotein. Additionally, male gender, age > 40 years, duration of diabetes > 10 years, obesity, hypertension, and HbA1c > 7% were found to be significant predictors of developing retinopathy. Moreover, it was observed that presence of neuropathy was associated with male gender, age ≥ 40 years, duration of diabetes > 10 years, obesity, hypertension, HbA1c > 7%, hypercholesterolemia, hypertriglyceridemia, and low HDL (Table 4).

Table 4 Stepwise multivariate logistic regression models

Discussion

The present study analyzed the microvascular complication profile of T2DM subjects at presentation for the first time attending a tertiary care unit of Karachi, Pakistan. The occurrence of any one of the microvascular complications in this study was 56.9% which was comparable to a study by Santos AD et al. in which they observed microvascular complications in 53.8% of type 2 diabetics [20]. Current study observed similar prevalence of microvascular complications as reported by us from the same tertiary care unit 13 years back except for neuropathy which is slightly higher as compared to previous one [12, 14,15,16]. According to our findings, neuropathy was the most common complication as compared to other complications. Similar outcomes were observed in previous studies from India and other countries from the region [21, 22]. However, some studies conducted in Hong Kong, Jammu and Kashmir, India reported nephropathy as the most common microvascular complication [23, 24].

Retinopathy seems to be the least common microvascular complication in this study population, and the findings are consistent with the earlier study done in Faisalabad, Pakistan [25]. In contrast, a study by Sohail observed higher prevalence of retinopathy (56.9%) among Pakistani individuals [26]. More sensitive screening tool along with the involvement of a trained ophthalmologist could have a better screening result for future studies.

Poor glycemic control, hypertension, gender, and longer duration of diabetes were found to be prominent risk factors of microvascular complications in this study. Comparable findings have been recorded where these factors were reported as contributing factors in progression of microvascular complications [7, 16, 27,28,29].

Results of the present study provide evidence that older people were at greater risk for the development of diabetes complications particularly retinopathy and neuropathy as reported by other researchers [5, 28, 30, 31]. Previous studies examined positive relationship between obesity and microvascular complications in type 2 diabetes [32, 33]. Similar outcomes were observed in current study. Previously, it was well defined that dyslipidemia causes risk of developing microvascular complications [5, 28, 34]. Our findings also showed significant association of hypercholesterolemia, hypertriglyceridemia, and low HDL with neuropathy and nephropathy. In contrast, no significant association of LDL cholesterol was found with any microvascular complication.

Limitations of this study include its retrospective design focusing only microvascular complications. Another limitation was the diagnosis of retinopathy, based on fundoscopy instead of using more sensitive screening tool like fundal photography. Additionally, it was single tertiary care center-based study and not a community survey as prevalence of diabetic complications may vary in a community-based survey.

Conclusion

High prevalence of microvascular complications was observed among type 2 diabetic subjects who visited for the first time in a tertiary care hospital. Male gender, age ≥ 40 years, duration of diabetes > 10 years, obesity, hypertension, HbA1c > 7%, and low HDL were strongly associated with any type of microvascular complication. These outcomes need to be validated by multicentered or larger-scale community-based studies. Early identification and effective management are required at primary and secondary care levels to combat this situation.